MedTrace Logo

Dynamic ctDNA Detection for Colorectal Cancer Liver Metastases

NCT06404593 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 270

Last updated 2024-05-08

No results posted yet for this study

Summary

Evaluating the value of dynamic monitoring of a colorectal cancer liver metastasis cohort underwent curative resection after receiving multipoint ctDNA detecting in predicting recurrence prognosis and guiding adjuvant chemotherapy treatment.

Conditions

  • Liver Metastases
  • Colorectal Cancer
  • Surgery
  • Circulating Tumor DNA
  • Minimal Residual Disease

Interventions

DIAGNOSTIC_TEST

Blood sampling

Evaluating the value of dynamic monitoring of a colorectal cancer liver metastasis cohort after receiving multipoint ctDNA detecting in predicting recurrence prognosis and guiding adjuvant chemotherapy treatment.

Sponsors & Collaborators

  • Peking University Cancer Hospital & Institute

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-18
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06404593 on ClinicalTrials.gov